Conference Coverage
Conference Coverage
Synthetic drugs pose regulatory, diagnostic challenges
SAN FRANCISCO – Every year brings about 250 novel recreational drugs.
Conference Coverage
Tanezumab acts fast for OA pain relief
TORONTO – The nerve growth factor inhibitor separated from placebo in the first 3-5 days in a phase 3 randomized, controlled trial.
Conference Coverage
SEER data show that pancreatic cancer mortality rates differ by ethnicity
SAN DIEGO – Between 2013 and 2015, mortality rates began to fall among all ethnicities, for reasons that remain unclear.
Conference Coverage
mTORC1 inhibitor protects elderly asthmatics from viral respiratory tract infections
DALLAS – By boosting innate immunity, RBT101 protects against rhinovirus respiratory infections and decreases the asthma exacerbations that can be...
Conference Coverage
CABANA: Heart failure patients got biggest bang from AFib ablation
SAN FRANCISCO – A CABANA trial subanalysis showed that patients with any heart failure type had the greatest benefit from AFib catheter ablation...
Conference Coverage
Nintedanib cut lung function decline in interstitial lung disease with systemic sclerosis
DALLAS – A decline in FVC is a good surrogate marker of mortality in interstitial lung disease associated with...
Video
Button batteries that pass to the stomach may warrant rapid endoscopic removal
Conference Coverage
Rifaximin effective for uncomplicated diverticulitis in real-life study
SAN DIEGO – SUDD affects about 20% of patients having diverticulosis.
Conference Coverage
Type 2 diabetes remission: Reducing excess fat in the liver might be the key
LOS ANGELES – ...
Conference Coverage
CardioMEMS cuts heart failure hospitalizations in post-approval study
NEW ORLEANS – In its post-approval study with 1,200 patients at 104 U.S. sites, CardioMEMS produced heart failure...
Conference Coverage
AFib screening cuts hospitalizations and ED visits
NEW ORLEANS –